BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 10222625)

  • 1. [Treatment of malignant lymphoma with extranodal lesions--current trends and new strategies in chemotherapy].
    Okumura H
    Rinsho Ketsueki; 1999 Mar; 40(3):196-8. PubMed ID: 10222625
    [No Abstract]   [Full Text] [Related]  

  • 2. CBVPM/AVBP versus HCOMLA chemotherapy in non-Hodgkin lymphoma patients.
    Pawelski S; Konopka L; Pakulska J; Gutkowska J
    Chemioterapia; 1987 Jun; 6(2 Suppl):716-9. PubMed ID: 2475265
    [No Abstract]   [Full Text] [Related]  

  • 3. A clinical phase II study of ProMACE-CytaBOM.
    Dahlberg S; Miller TP; Fisher RI
    J Clin Oncol; 1991 May; 9(5):888. PubMed ID: 1707958
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of localized lymphoma.
    Hoecht S; Hinkelbein W
    N Engl J Med; 2005 Jun; 352(23):2449-51; author reply 2449-51. PubMed ID: 15948267
    [No Abstract]   [Full Text] [Related]  

  • 5. Defining the stages of aggressive non-Hodgkin's lymphoma--a work in progress.
    Armitage JO
    N Engl J Med; 2005 Mar; 352(12):1250-2. PubMed ID: 15788502
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of localized lymphoma.
    Adli M; Sevinc A; Kalender ME
    N Engl J Med; 2005 Jun; 352(23):2449-51; author reply 2449-51. PubMed ID: 15948268
    [No Abstract]   [Full Text] [Related]  

  • 7. [Lactic acidosis in non-Hodgkin's lymphoma].
    Navigante AH; Chacón RD
    Medicina (B Aires); 1985; 45(6):667-9. PubMed ID: 2431249
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of localized lymphoma.
    Tanvetyanon T
    N Engl J Med; 2005 Jun; 352(23):2449-51; author reply 2449-51. PubMed ID: 15944432
    [No Abstract]   [Full Text] [Related]  

  • 9. Results of three polychemotherapy programs in non-Hodgkin's lymphomas.
    Konopka L; Pawelski S
    J Chemother; 1989 Jul; 1(4 Suppl):1259-62. PubMed ID: 16312857
    [No Abstract]   [Full Text] [Related]  

  • 10. [Problems of cancer treatment in the elderly from the viewpoint of the chemotherapist--focusing on malignant lymphomas as a model of chemotherapy].
    Oyama A; Suzuki H; Ogura M
    Gan To Kagaku Ryoho; 1990 Apr; 17(4 Pt 2):858-61. PubMed ID: 2188607
    [No Abstract]   [Full Text] [Related]  

  • 11. Bone marrow transplantation versus chemotherapy in non-Hodgkin's lymphoma.
    Fielding AK; Pearce RM; Goldstone AH
    N Engl J Med; 1995 Sep; 333(11):729; author reply 730. PubMed ID: 7637758
    [No Abstract]   [Full Text] [Related]  

  • 12. [Recent advances and the treatment strategies of AIDS-related malignant lymphoma].
    Okada S
    Rinsho Ketsueki; 2008 Oct; 49(10):1490-8. PubMed ID: 18833933
    [No Abstract]   [Full Text] [Related]  

  • 13. New treatment strategies for aggressive lymphoma.
    Younes A
    Semin Oncol; 2004 Dec; 31(6 Suppl 15):10-3. PubMed ID: 15726533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Liver damage in lymphoma and its clinical significance].
    Pan JX
    Zhonghua Zhong Liu Za Zhi; 1993 May; 15(3):224-6. PubMed ID: 7505218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclophosphamide, epirubicin, vincristine, and prednisone (CEOP) in the treatment of advanced stage non-Hodgkin's lymphomas with poor histology.
    Comella P; Abate G; Fiore M; Di Finizio G; Zarrilli D
    J Chemother; 1989 Jul; 1(4 Suppl):1257-8. PubMed ID: 16312856
    [No Abstract]   [Full Text] [Related]  

  • 16. What is the treatment of choice for advanced-stage Hodgkin's lymphoma: ABVD, Stanford V, or BEACOPP?
    Hehn ST; Miller TP
    Curr Hematol Rep; 2004 Jan; 3(1):17-26. PubMed ID: 14695845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical features of extranodal malignant lymphoma--staging classification and treatment strategies].
    Takagi T
    Rinsho Ketsueki; 1999 Mar; 40(3):188-91. PubMed ID: 10222623
    [No Abstract]   [Full Text] [Related]  

  • 18. Chemoradiotherapy for localized non-Hodgkin's lymphoma: lessons from old studies.
    Basaran G; Basaran M; Onat H
    J Clin Oncol; 2005 May; 23(13):3161-2; author reply 3162-3. PubMed ID: 15860887
    [No Abstract]   [Full Text] [Related]  

  • 19. What constitutes "improved prognosis"?
    Canellos GP
    J Clin Oncol; 2008 Apr; 26(12):1913-4. PubMed ID: 18421041
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical features, treatment and prognosis of 136 patients with primary non-Hodgkin's lymphoma of the nasopharynx].
    Yuan ZY; Li YX; Zhao LJ; Gao YH; Liu XF; Gu DZ; Qian TN; Yu ZH
    Zhonghua Zhong Liu Za Zhi; 2004 Jul; 26(7):425-9. PubMed ID: 15355649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.